Frequently Asked Questions

Clinovare primarily supports small to mid-size biotech and pharmaceutical sponsors, CROs, and clinical research sites, across Phase 1 through Phase IV clinical development.

Clinovare offers six core services: Clinical Monitoring Services, Clinical Resource Support, Strategic Clinical Operations Support (Sponsor-Embedded), GCP Auditing for sponsors/CROs/sites, Medical Monitoring & Medical Director Support, and Medical Writing Services. Services may be engaged individually or combined based on program needs.

Yes. Clinovare supports clinical programs across Phase I through Phase IV, tailoring monitoring, operational oversight, medical monitoring, medical writing, and auditing approaches based on trial complexity, risk, and regulatory requirements.

Clinovare focuses on execution quality, oversight, and flexibility rather than full-service outsourcing. We integrate into existing teams, strengthen accountability, and provide senior-level expertise without unnecessary layers.

Yes. Embedded resources operate under sponsor or CRO SOPs and direction, while Clinovare-managed services follow agreed-upon processes aligned with regulatory expectations.

Absolutely. Inspection readiness is embedded into our daily execution across monitoring, operations, and auditing services. We also provide targeted inspection readiness assessments and support.

Timelines vary by role and scope, but Clinovare is designed for rapid deployment, often onboarding qualified resources within weeks rather than months.

Medical Monitoring focuses on medical oversight and subject safety, including protocol interpretation, safety signal review, eligibility guidance, and clinical decision support. Clinical Operations support focuses on trial execution, including monitoring oversight, CRO governance, vendor management, and inspection readiness. Clinovare ensures strong alignment between medical and operational functions to reduce risk and improve trial quality.

Yes. Clinovare provides flexible medical consulting support, including interim, part-time, or project-based Medical Monitors and Medical Directors. These roles may be sponsor-embedded or aligned with specific trials or programs.

Medical Monitor assignments are aligned with therapeutic experience and trial phase requirements whenever possible. We work closely with sponsors to ensure appropriate expertise and fit for each engagement.

Absolutely. Medical writing is often combined with clinical operations, medical monitoring, or GCP auditing services to ensure consistency between trial execution, medical oversight, and documentation.

Yes. Clinovare supports Phase 1 through Phase IV programs, including early-phase trials that require hands-on medical oversight, close safety monitoring, and tight operational coordination.

Absolutely. Many clients engage Clinovare for a combination of services. For example, clinical monitoring, medical monitoring, medical writing, and GCP auditing, can be combined to ensure consistency, accountability, and inspection readiness across the program.

Inspection readiness is built into all Clinovare services. From monitoring execution and medical review to auditing and documentation oversight, we emphasize proactive risk identification, strong documentation practices, and cross-functional alignment.

Clinovare provides medical writing support across all phases of clinical development, including: clinical trial protocols and amendments, informed consent forms (ICFs), pharmacy manuals and investigational product documentation, investigator brochures and study manuals, and other clinical and regulatory medical writing needs. Our medical writing is developed with direct input from clinical operations and medical leadership to ensure clarity, consistency, and inspection readiness.